Oakrum Pharma, LLC Email Format
Pharmaceutical ManufacturingMissouri, United States0-1 Employees
Oakrum Pharma, LLC is a privately owned pharmaceutical manufacturer based in St. Louis, Missouri. The company concentrates on developing and commercializing therapies for rare diseases and other specialty products that address significant unmet clinical needs. Oakrum has brought several generic medicines to market, including pyrimethamine 25 mg tablets in 2020 and a methylprednisolone 4 mg tablet in 2019, with the latter developed in collaboration with SunGen Pharma. In 2022, the company partnered with ANI Pharmaceuticals to launch a generic version of Cystadane (betaine anhydrous) powder for oral solution, accompanied by 180 days of exclusivity.